AFYREN (FR:ALAFY)

:ALAFY

ALAFY

AFYREN

RESEARCH TOOLSreports

Want to see FR:ALAFY full AI Analyst Report?

AFYREN (ALAFY) Price & Analysis

1 Followers

ALAFY Stock Chart & Stats

€2.85

-€0.20(-8.37%)

At close: Jan 09 4:00 PM EST

€2.85

-€0.20(-8.37%)

Day’s Range― - ―

52-Week Range€2.07 - €3.24

Previous CloseN/A

Volume19.43K

Average Volume (3M)10.93K

Market Cap

€112.67M

Enterprise Value€45.19M

Total Cash (Recent Filing)€35.16M

Total Debt (Recent Filing)€2.42M

Price to Earnings (P/E)―

Beta-0.16

Next Earnings

Sep 25, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.53

Shares Outstanding38,852,520

10 Day Avg. Volume15,238

30 Day Avg. Volume10,926

Financial Highlights & Ratios

PEG Ratio-0.12

Price to Book (P/B)1.22

Price to Sales (P/S)33.31

P/FCF Ratio-14.32

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-0.41

Revenue Forecast (FY)€3.15M

Bulls Say, Bears Say

Bulls Say

Proprietary Fermentation TechnologyAFYREN's proprietary fermentation process is a durable competitive asset: it enables production of renewable organic acids from biomass residues, creates technical barriers to entry, and aligns the company with long-term secular demand for sustainable chemical substitutes across industries, supporting lasting product differentiation and customer lock-in.

Diversified End-market ExposureServing multiple end markets spreads demand risk and increases commercial optionality. Exposure to food, cosmetics, pharma and industrial applications gives many routes to scale and multiple potential offtake channels, reducing dependence on any single sector and supporting steadier revenue opportunities over time.

Low Leverage And Stronger Equity BaseA comparatively clean balance sheet with modest debt provides financial flexibility and runway while the company scales. Lower leverage reduces insolvency risk, supports the ability to raise project financing or absorb short-term cash burn, and preserves strategic optionality during the industrialization phase.

Bears Say

Sustained Revenue DeclineTwo consecutive years of double-digit revenue declines signal weak commercial traction or demand shifts. Loss of scale erodes unit economics and makes fixed-cost absorption harder, lengthening the timeline to profitable operations and complicating contract offtake scaling critical for durable revenue recovery.

Persistent Negative Operating And Free Cash FlowConsistent negative cash flow forces reliance on external financing and constrains reinvestment into manufacturing scale-up. Ongoing cash burn increases dilution or refinancing risk, limits ability to fund commercialization, and creates structural pressure on management to restore self-funded growth.

Widening Losses And Gross Loss In 2025A gross loss indicates production economics or cost allocation issues that directly undermine core profitability. Widening net losses increase the urgency of margin recovery or cost restructuring; without durable improvements to gross margins, scaling revenue will not translate into sustainable earnings.

ALAFY FAQ

What was AFYREN’s price range in the past 12 months?

AFYREN lowest stock price was €2.06 and its highest was €3.23 in the past 12 months.

What is AFYREN’s market cap?

AFYREN’s market cap is €112.67M.

When is AFYREN’s upcoming earnings report date?

AFYREN’s upcoming earnings report date is Sep 25, 2026 which is in 98 days.

How were AFYREN’s earnings last quarter?

AFYREN released its earnings results on Mar 31, 2026. The company reported -€0.264 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.264.

Is AFYREN overvalued?

According to Wall Street analysts AFYREN’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does AFYREN pay dividends?

AFYREN does not currently pay dividends.

What is AFYREN’s EPS estimate?

AFYREN’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does AFYREN have?

AFYREN has 38,852,520 shares outstanding.

What happened to AFYREN’s price movement after its last earnings report?

AFYREN reported an EPS of -€0.264 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.099%.

Which hedge fund is a major shareholder of AFYREN?

Currently, no hedge funds are holding shares in FR:ALAFY

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

AFYREN

Afyren SAS is a French sustainable chemical firm that manufactures biomolecules by repurposing non-food biological waste. These specialized molecules are utilized across a variety of sectors, including human and animal nutrition, the production of flavors and fragrances, as well as applications in life sciences, material sciences, and lubricants. Their product offerings primarily include a range of biosourced organic acids, specifically acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, and caproic acid. The company was established in 2012 and has its headquarters in Clermont-Ferrand, France.